Partnering

INSIGHTS ON CLINICAL TRIAL PARTNERING

Site Management Support To Investigational Sites
Rare disease trials demand specialized site support. Explore how tailored site management practices can improve consistency, data quality, and patient engagement in complex clinical studies.
Continuity And Risk Mitigation Following Unexpected QPPV Resignation
Rapid escalation and clear interim governance ensured compliance and operational continuity following an unexpected QPPV resignation, reducing inspection risk during a critical pharmacovigilance transition.
Transforming Clinical Trial Sites With Research Study Rockstar
This innovative platform streamlines workflows, automates patient communication, and provides intuitive dashboards to address prevalent pain points faced by trial coordinators.
Unlocking Recruitment Potential In Trial-Naïve Sites
Site Professional Support enabled this late-phase rheumatoid arthritis study to conduct complex patient visits despite its use of sites that lacked research experience and resources.

Scalable Payments For Global Clinical Studies
2/11/2026

How does a global clinical trial scale change payment behavior, and how can teams spot when payment operations start slowing execution?
Clinical Trial Budgeting Faces Pressure To Modernize
6/26/2026

Outdated budget data slows trial startup. Real-time market benchmarking helps sites and sponsors negotiate faster and get treatments to patients sooner.
Challenges That Derail Bladder Cancer Trials And How To Anticipate Them Earlier
3/5/2026

From the rapid evolution of standard-of-care benchmarks to the logistical strain of procedure-heavy urology workflows, the path to a successful endpoint is filled with operational friction.
Why The TrialKit Platform License Agreement Changes The Economics Of Clinical Trials
2/24/2026

A platform‑based pricing model removes change‑order friction, enabling predictable budgets and faster study adjustments. It supports operational agility and portfolio‑level efficiency as trials evolve.
Reduction Of Screen Failures In A Biomarker
2/24/2026

Targeted prescreening for biomarker and cognitive criteria cut screen failures in a complex Alzheimer’s trial, speeding enrollment and improving site efficiency while maintaining strict eligibility.

Late Stage Customization

Learn about the benefits of a Late Stage Customization approach, including how it can support a leaner, more responsive supply chain, ensuring life-changing therapies reach patients more efficiently.
One Home for Sites™ Partnership Program Guide

Learn how your organization can become part of One Home for Sites, the only platform that’s bringing the industry together to help sites survive and thrive, along with their patients.
Simplify Your Sites Operations, Patient Payments, Travel, And Logistics

Simplify patient support in clinical trials through comprehensive expense management, travel coordination, and site services designed to reduce the burden on sites and participants.
Full-Service Clinical Development Solutions

Getting a novel therapy through the clinical development process to approval is complicated. Unearth how to advance novel medical therapies from Phase I-III clinical development to market with confidence.
Human ADME Studies: Human Metabolism Data For Regulatory Submission

Integrated human ADME studies streamline the process from 14C synthesis to clinical conduct and final reporting to accelerate your drug development program.